Home » FDA Clears Bio-Rad’s BioPlex 2200 Anti-CCP Test
FDA Clears Bio-Rad’s BioPlex 2200 Anti-CCP Test
Bio-Rad Laboratories Inc. and Axis-Shield plc announced FDA clearance and U.S. launch of Bio-Rad’s BioPlex 2200 Anti-CCP test for the early detection of rheumatoid arthritis.
RTTNews
RTTNews
Upcoming Events
-
07May
-
14May
-
30May